$WVE 3 SEC Filings

Filed On	Filing
17 Apr 2026	Form 3: Wright Christopher I, Chief Medical Officer Holds 45,625 shares of Ordinary Shares
17 Apr 2026	Form 3: Ingelsson Erik, Chief Scientific Officer Holds 87,864 shares of Ordinary Shares
30 Jan 2023	Form 3: Gsk Plc, 10% owner Holds 10,683,761 shares of Ordinary Shares
11 Dec 2020	Form 3: Moran Kyle, Chief Financial Officer Holds 20,084 shares of Ordinary Shares
20 Aug 2020	Form 3: Tan Aik Na, Director No securities owned
17 Jan 2020	Form 3: Gaiero David G, Interim CFO Holds 7,043 shares of Ordinary Shares
06 Sep 2019	Form 3: Corrigan Mark, Director No securities owned
06 Sep 2019	Form 3: Wagner Heidi L, Director No securities owned
06 Sep 2019	Form 3: Pott Amy, Director No securities owned
07 Aug 2019	Form 3: Baldry Mark, Chief Commerical Officer No securities owned
01 Feb 2017	Form 3: Rawcliffe Adrian, Director No securities owned
14 Nov 2016	Form 3: Henry Christian O, Director No securities owned
17 Aug 2016	Form 3: Regnante Keith, Chief Financial Officer No securities owned
13 Jul 2016	Form 3: Panzara Michael A., Franchise Lead, Neurology No securities owned
12 Nov 2015	Form 3: Ra Capital MANAGEMENT, Llc, Director and 2 others Holds 4,041,591 shares of Ordinary Shares
10 Nov 2015	Form 3: Tanaka Masaharu, Director and 1 other Holds 2,990,777 shares of Ordinary Shares
10 Nov 2015	Form 3: Takanashi Ken, Director and 1 other Holds 1,697,467 shares of Ordinary Shares
10 Nov 2015	Form 3: Moran Kyle, See Remarks
10 Nov 2015	Form 3: Francis Chris, See Remarks
10 Nov 2015	Form 3: Wada Takeshi, Director Holds 100,635 shares of Ordinary Shares

Comments